FDAnews
www.fdanews.com/articles/176097-profound-medical-snags-ce-mark-for-tulsa-pro

Profound Medical Snags CE Mark for TULSA-PRO

April 11, 2016

Profound Medical has received CE marking for its TULSA-PRO, a minimally invasive therapy for prostate care.

The therapy’s technology joins magnetic resonance imaging and transurethral ultrasound and closed-loop thermal feedback control to provide precise ablation.

The launch of the therapy in Europe will begin immediately. — Anisa Jibrell